SCHEMBL8034133

SCHEMBL8034133

Cn1nc(C(C)(C)C)c2nc(N(CCN3CCOCC3)CC3CC3)[nH]c(=O)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
PDE9A O76083 1/20 0.34
PDE1A P54750 1/20 0.34
PDE1B Q01064 1/20 0.34
PDE1C Q14123 1/20 0.34
ALDH1A1 P00352 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
MAPT P10636 1/20 0.34
POLB P06746 3/20 0.33
PDE5A O76074 3/20 0.32
PDE6C P51160 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
HTT P42858 2/20 0.32
LMNA P02545 1/20 0.32
HIF1A Q16665 1/20 0.32
MCOLN3 Q8TDD5 1/20 0.32
USP2 O75604 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4123024 0.90 ALDH1A1 (0.36) KDM4EPDE9APDE1APDE1BPDE1C
SCHEMBL8042659 0.88 KDM4E (0.37) KDM4EALDH1A1SMN1; SMN2NPSR1MAPT
SCHEMBL4134627 0.87 MAPT (0.34) KDM4EALDH1A1NPSR1MAPTPOLB
SCHEMBL8048797 0.86 PDE9A (0.38) KDM4EPDE9APDE1APDE1BPDE1C
SCHEMBL4132580 0.85 KDM4E (0.35) KDM4EALDH1A1SMN1; SMN2NPSR1MAPT
SCHEMBL8033607 0.85 KDM4E (0.36) KDM4EALDH1A1SMN1; SMN2NPSR1MAPT
SCHEMBL4139405 0.83 KDM4E (0.34) KDM4EALDH1A1SMN1; SMN2NPSR1MAPT
SCHEMBL4131082 0.82 MAPT (0.34) KDM4EALDH1A1SMN1; SMN2NPSR1MAPT
SCHEMBL8045132 0.82 KDM4E (0.41) KDM4EALDH1A1SMN1; SMN2NPSR1MAPT
SCHEMBL8043859 0.82 KDM4E (0.36) KDM4EPDE9APDE1APDE1BPDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071707-A1 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed